![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
NAFLD and risk of incident steatohepatitis, cirrhosis and
hepatocellular carcinoma in four European primary care databases
|
|
|
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Dr William Alazawi MA(Cantab) PhD FRCP
Reader and Consultant in Hepatology
Queen Mary, University of London
![0418181](../images%20/041818/041818-1/0418181.gif)
![0418182](../images%20/041818/041818-1/0418182.gif)
![0418183](../images%20/041818/041818-1/0418183.gif)
![0418184](../images%20/041818/041818-1/0418184.gif)
![0418185](../images%20/041818/041818-1/0418185.gif)
![0418186](../images%20/041818/041818-1/0418186.gif)
![0418187](../images%20/041818/041818-1/0418187.gif)
![0418188](../images%20/041818/041818-1/0418188.gif)
![0418189](../images%20/041818/041818-1/0418189.gif)
![04181810](../images%20/041818/041818-1/04181810.gif)
![04181811](../images%20/041818/041818-1/04181811.gif)
![04181812](../images%20/041818/041818-1/04181812.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|